Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
72%
Virus
43%
Neutralization
37%
Aspergillus
37%
Omicron Coronavirus Variant
37%
Viral Load
37%
Filamentous Fungus
18%
Gene Deletion
18%
Oryza
18%
Heterologous Expression
18%
Gene Cluster
18%
Hybrid Gene
18%
Peptides
18%
Breakthrough Infection
14%
Plaque-Forming Unit
9%
Antibody Response
9%
Viral Shedding
9%
Feces
6%
Rectum
6%
Virus Infectivity
6%
Reverse Transcription Polymerase Chain Reaction
6%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
61%
Infection
46%
Surgical Infection
37%
Aspergillus
37%
Antibiotics
18%
Antiinfective Agent
12%
Filamentous Fungus
12%
Cytochrome P450
12%
Drug Release
12%
Staphylococcus Aureus
6%
Healthcare Associated Infection
6%
Infectious Agent
6%
Rifampicin
6%
Minocycline
6%
Foreign Body
6%
Microorganism
6%
Medicine and Dentistry
COVID-19
37%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
Infection
37%
Surgical Infection
37%
Throat Culture
18%
Antibiotics
18%
Virus Infectivity
6%
In Vitro
6%
Feces
6%
Antimicrobial Activity
6%
Antiinfective Agent
6%
Healthcare Associated Infection
6%
Surgical Technique
6%
Foreign Body
6%
Staphylococcus Aureus
6%
Pharynx
6%
Reverse Transcription Polymerase Chain Reaction
6%
Pathogen
6%
Cohort Analysis
6%
Rifampicin
6%
Health Care Cost
6%
Blood Vessel Graft
6%
Virus
6%
